Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1198
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMahasen Juaton, Lynette Cussack-
dc.contributor.authorTim Schultz-
dc.date.accessioned2022-06-06T07:59:14Z-
dc.date.available2022-06-06T07:59:14Z-
dc.date.issued2020-02-12-
dc.identifier.issn1447‑4328-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/1198-
dc.descriptionContinually returning once every four weeks to an out-patient department to complete an intravenous infusion can be taxing for chronic disease patients. In Australia, acute care patients may be offered hospital in the home service. In-home services are delivered by highly qualified, trained nurses following the infusion protocols similar to that of the hospital. However, this service is not yet offered for chronic disease patients, such as those with relapsing remitting multiple sclerosis.en_US
dc.description.abstractThis study’s objective was to understand the experiences and perspectives of people with multiple sclerosis who received infusions of natalizumab at home instead of the tertiary hospital day unit.en_US
dc.language.isoen_USen_US
dc.publisherAustralian Nursing & Midwifery Federationen_US
dc.subjecthospital infusionen_US
dc.subjecthome infusionen_US
dc.subjectpatientcentreden_US
dc.titlePatients’ experiences of natalizumab treatment in a home environment: a qualitative studyen_US
dc.typeArticleen_US
Appears in Collections:2. Australian Journal of Advanced Nursing

Files in This Item:
File Description SizeFormat 
2.pdf64.19 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.